Top 10 Companies in the Pharmaceutical Cellulose Derivative Excipient Market (2026): Industry Leaders Powering Drug Formulations

In Business Insights
March 16, 2026

The Global Pharmaceutical Cellulose Derivative Excipient Market was valued at USD 3.5 Billion in 2025 and is projected to reach USD 6.1 Billion by 2034, growing at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period (2024-2030). This growth is driven by increasing demand for oral solid dosage forms, expansion of generic medicines, and the development of advanced controlled-release drug delivery systems.

As the pharmaceutical industry moves toward more sophisticated formulations and sustainable production, cellulose derivatives like Microcrystalline Cellulose (MCC) and Hypromellose (HPMC) have become indispensable. In this analysis, we profile the Top 10 Companies in the Pharmaceutical Cellulose Derivative Excipient Industry – a mix of chemical conglomerates, specialized manufacturers, and innovators shaping the future of pharmaceutical formulations.


🔟 1. International Flavors & Fragrances (IFF)

Headquarters: New York, USA
Key Offering: Methocel™ (HPMC), Avicel® (MCC), Ethocel™ (Ethyl Cellulose)

IFF Pharma Solutions (formerly DuPont Nutrition & Biosciences) is a global leader in cellulose derivative excipients, offering a comprehensive portfolio for tablet binding, film coating, and controlled release applications. Their Avicel® MCC line is widely regarded as the industry standard for direct compression.

Innovation Initiatives:

  • Development of co-processed excipients for improved functionality

  • Investment in continuous manufacturing technologies

  • Focus on sustainable sourcing of cellulose raw materials

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/306827/pharmaceutical-cellulose-derivative-excipient-market


9️⃣ 2. JRS Pharma

Headquarters: Rosenberg, Germany
Key Offering: Vivapur® (MCC), Vivapharm® (HPMC), Vivastar® (Povidone)

JRS Pharma specializes in pharmaceutical excipients with a strong focus on cellulose derivatives. Their technical expertise in particle engineering enables customized solutions for specific formulation challenges.

Innovation Initiatives:

  • Spray-dried MCC grades for improved flow and compression

  • Specialty HPMC grades for hot melt extrusion


8️⃣ 3. Shin-Etsu Chemical Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Metolose® (HPMC), Ceolus™ (MCC)

Shin-Etsu is a leading global producer of high-purity cellulose ethers, known for their consistent quality and reliable supply chain. Their Metolose® HPMC grades are widely used in global pharmacopeias.

Innovation Initiatives:

  • Development of enteric HPMC formulations

  • Investment in plant-based cellulose sources


7️⃣ 4. Ashland Global Holdings

Headquarters: Wilmington, Delaware, USA
Key Offering: Benecel™ (HPMC), Klucel™ (HPC), Blanose™ (CMC)

Ashland offers a broad portfolio of cellulose derivatives with pharmaceutical applications ranging from tablet binding to extended-release matrix systems.

Innovation Initiatives:

  • Functional grade development for specific API compatibilities

  • Chemical modification for enhanced thermal stability

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/306827/pharmaceutical-cellulose-derivative-excipient-market


6️⃣ 5. Asahi Kasei Corporation

Headquarters: Tokyo, Japan
Key Offering: Asahi Kasei Cellulose (MCC, HPMC)

Asahi Kasei manufactures pharmaceutical-grade cellulose derivatives with a focus on the Asian market, serving major generic drug manufacturers and CMOs.

Innovation Initiatives:

  • Development of high-density MCC grades

  • Expansion of dissolution-modifying HPMC line


5️⃣ 6. DFE Pharma

Headquarters: Goch, Germany
Key Offering: Vivapur® (MCC), Vivastar® (Copovidone)

DFE Pharma specializes in excipients for solid dosage forms, with a strong cellulose derivative portfolio acquired from JRS Pharma.

Innovation Initiatives:

  • Particle engineering for improved API-excipient interaction

  • Development of multifunctional excipient blends


4️⃣ 7. Mingtai Chemical Co., Ltd.

Headquarters: Taiwan, China
Key Offering: HPMC, CMC, Methyl Cellulose

Mingtai is a leading Asian manufacturer of cellulose ethers with growing penetration in regulated markets through cGMP compliance.

Innovation Initiatives:

  • Expansion of production capacity for pharmaceutical grades

  • Development of low-substituted HPMC variants


3️⃣ 8. Huzhou Zhanwang Pharmaceutical Co., Ltd.

Headquarters: Zhejiang, China
Key Offering: HPMC, MCC, EC

Zhanwang Pharma is one of China’s largest manufacturers of pharmaceutical excipients with increasing international market presence.

Innovation Initiatives:

  • Implementation of continuous manufacturing processes

  • Quality system upgrades for regulatory compliance

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/306827/pharmaceutical-cellulose-derivative-excipient-market


2️⃣ 9. Shandong Head Co., Ltd.

Headquarters: Shandong, China
Key Offering: HPMC, Industrial MCC

Shandong Head specializes in cellulose ether production with growing capabilities in pharmaceutical-grade materials.

Innovation Initiatives:

  • Expansion into pharmaceutical MCC market

  • Automation of production facilities


1️⃣ 10. Accent Microcell

Headquarters: Ahmedabad, India
Key Offering: Microcrystalline Cellulose (MCC)

Accent Microcell is a leading Indian manufacturer of high-quality MCC, serving domestic and international pharmaceutical markets.

Innovation Initiatives:

  • Development of specialty MCC grades for ODTs

  • Implementation of green chemistry principles

Get Full Report Here: https://www.24chemicalresearch.com/reports/306827/pharmaceutical-cellulose-derivative-excipient-market


🔬 Outlook: The Future of Cellulose Derivatives in Pharmaceutical Formulations

The pharmaceutical excipients market is undergoing significant transformation. While traditional applications still dominate, industry leaders are innovating to meet new formulation challenges.

📈 Key Trends Shaping the Market:

  • Growing demand for multifunctional excipient systems

  • Increasing adoption of continuous manufacturing processes

  • Focus on bio-based and sustainable excipient sources

  • Development of specialized grades for biologics and advanced therapies

Get Full Report Here: https://www.24chemicalresearch.com/reports/306827/pharmaceutical-cellulose-derivative-excipient-market

The companies listed above are not just supplying raw materials – they’re enabling pharmaceutical innovation through advanced excipient solutions.